Skip to main content
TipRanks
Go Ultimate75% OFF

Citius Oncology (CTOR) Income Statement

132 Followers

Citius Oncology Income Statement

Last quarter (Q3 2026), Citius Oncology's total revenue was $1.49M. In Q3, Citius Oncology's net income was $-8.92M. See Citius Oncology’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementSep 25Sep 24Sep 23Sep 22
$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00
$ 23.52M$ 20.57M$ 12.12M$ 9.71M
Depreciation and Amortization$ 0.00$ 0.00$ 0.00$ 9.71M
$ -23.49M$ -20.57M$ -12.12M$ 0.00
$ -23.52M$ -20.57M$ -12.12M$ -9.71M
$ -181.66K$ 0.00$ 0.00$ 0.00
$ -23.70M$ -20.57M$ -12.12M$ -9.71M
$ -24.76M$ -21.15M$ -12.70M$ -10.87M
Per Share Metrics
Basic EPS$ -0.34$ -0.30$ -0.19$ -0.08
Diluted EPS$ -0.34$ -0.30$ -0.19$ -0.08
Weighted Average Shares Outstanding73.27M71.55M89.48M90.16M
Weighted Average Shares Outstanding (Diluted)73.27M71.55M89.48M90.16M

Currency in USD

Citius Oncology Earnings and Revenue History

-30M-20M-10M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin